UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052333 |
|---|---|
| Receipt number | R000059370 |
| Scientific Title | The impact of alkalization therapy on cancer treatment: a retrospective observational study |
| Date of disclosure of the study information | 2023/09/28 |
| Last modified on | 2025/04/11 14:05:41 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The impact of alkalization therapy on cancer treatment: a retrospective observational study
Acronym
The impact of alkalization therapy on cancer treatment: a retrospective observational study
Scientific Title
The impact of alkalization therapy on cancer treatment: a retrospective observational study
Scientific Title:Acronym
The impact of alkalization therapy on cancer treatment: a retrospective observational study
Region
| Japan |
Condition
Condition
Patients with cancer
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This study aims to investigate the impact of Alkalization therapy on the treatment progress of cancer patients who are receiving it as an adjunctive therapy in addition to standard treatment.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Median overall survival for each type of cancer
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 90 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Individuals undergoing adjunctive cancer therapy
2. Men and women aged 20 to 90 at the time of data collection
Key exclusion criteria
1. Those who opt out and do not wish to participate in this study
2. Patients who visited less than two times
Target sample size
2000
Research contact person
Name of lead principal investigator
| 1st name | Reo |
| Middle name | |
| Last name | Hamaguchi |
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Division name
none
Zip code
604-0842
Address
119 Nishi-Oshikojicho, Nakagyo-ku, Kyoto City, Kyoto Prefecture
TEL
075-223-1100
reo-h@nifty.com
Public contact
Name of contact person
| 1st name | Reo |
| Middle name | |
| Last name | Hamaguchi |
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Division name
none
Zip code
604-0842
Address
119 Nishi-Oshikojicho, Nakagyo-ku, Kyoto City, Kyoto Prefecture
TEL
075-223-1100
Homepage URL
reo-h@nifty.com
Sponsor or person
Institute
Japanese Society on Inflammation and Metabolism in Cancer
Institute
Department
Personal name
Funding Source
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee of the ACCP Japanese Chapter
Address
54 Shogoin Kawaracho, Sakyo-ku, Kyoto City, Kyoto
Tel
075-751-3780
ishijim@kuhp.kyoto-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 09 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
1414
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2023 | Year | 08 | Month | 07 | Day |
Date of IRB
| 2023 | Year | 09 | Month | 21 | Day |
Anticipated trial start date
| 2023 | Year | 09 | Month | 28 | Day |
Last follow-up date
| 2024 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study retrospectively extracts data from medical records of patients who received adjunctive cancer therapy at Karasuma Wada Clinic and analyzes the median overall survival for each type of cancer.
Management information
Registered date
| 2023 | Year | 09 | Month | 28 | Day |
Last modified on
| 2025 | Year | 04 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059370
